3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Endometrial Neoplasms
3
Breast Neoplasms
3
Ovarian Neoplasms
2
Non Small Cell Lung Carcinoma NSCLC
2
Neoplasms
2
Neoplasm Metastasis
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcopenia
1
Penile Neoplasms
1
Non-Small Cell Lung Cancer With HER2- Mutations
1
Malnutrition
1
Male Urogenital Diseases
1
Lung Neoplasms
1
First-line Advanced NSCLC Patients
1
Fallopian Tube Neoplasms
1
Dysgeusia
1
Carcinoma
1
Interventions
Cisplatin
24
Paclitaxel
21
pembrolizumab
15
Radiotherapy
12
Fluorouracil
12
Carboplatin
12
Drug Therapy
11
tislelizumab
10
toripalimab
9
Irinotecan
8
Esophagectomy
8
Oxaliplatin
6
Nivolumab
6
Capecitabine
6
Radiation
5
Neoadjuvant Therapy
5
Leucovorin
5
lenvatinib
4
camrelizumab
4
Levoleucovorin
4
Immune Checkpoint Inhibitors
4
Docetaxel
4
130-nm albumin-bound paclitaxel
4
apatinib
3
Taxes
3
Itraconazole
3
Injections
3
Albumin-Bound Paclitaxel
3
spartalizumab
2
sintilimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
CP protocol
×
1 year
×
Clear all
No trials found.